Skip to content

Author

David M. Waterhouse

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Closing the HRR testing gap in advanced prostate cancer: Influence of audit-feedback on testing and sustainability.

584 Background: NCCN guidelines recommend germline testing and support biomarker-directed somatic homologous recombination repair (HRR) testing for men with high-risk (HR), very high-risk (VHR), regional, and metastatic prostate cancer, yet uptake remains suboptimal. A community oncology practice leveraged exis...

David M. Waterhouse, Mitch Singstock, D. Davies et al. · 0 citations
Open access Sep 2026

Geographic access to triple negative breast cancer clinical trials: are trials located near patients?

Trial availability was significantly lower in counties with the highest health vulnerability and in rural counties, which were more likely to rely exclusively on federally sponsored trials, and in rural counties, which were more likely to rely exclusively on federally sponsored trials.

L. B. Amin, M. Kirkwood, Laura A. Levit et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.